EU Grants Over €11 Million to University of Galway for Medical Innovations

Researchers at the University of Galway have received more than €11 million in funding from the European Union. This financial support is designated for innovative projects aimed at enhancing medical treatments. The funding comes under the European Commission’s Marie Sklodowska Curie Actions-Doctoral Network programme, which promotes research and training across Europe.

One of the major initiatives will be led by Dr. Eimear Morrissey, who is heading a €4.4 million research project focused on clinical trials. This project aims to ensure inclusivity for older adults, ethnic minorities, individuals with disabilities, and those from lower-income backgrounds. The goal is to develop new tools, methods, and policies that enhance the fairness and effectiveness of clinical trials throughout Europe.

In another significant project, Dr. Mihai Lomora will oversee the €4.2 million CerebroMachinesTrain Doctoral Network. This initiative will utilize advanced 3D brain models that accurately replicate real brain tissue. The research will explore the efficacy of tiny machines designed to deliver medication precisely where it is needed in the body.

Additionally, Dr. William Ronan will lead the €2.7 million MEDALLOY research project. This initiative focuses on developing stronger and longer-lasting materials for life-saving devices, concentrating on minimally invasive implants such as stents and heart valve supports.

Also noteworthy is a collaborative effort involving Dr. Muireann O’Cinneide, who is partnering with Goldsmiths, University of London and the Cúirt International Festival of Literature. Their project, titled DECADOCS – Decadent Travellers and the Reception of Classical Antiquity, stands out as the first doctoral network dedicated to the study of decadence, a societal phenomenon often linked to decline and decay.

These projects not only highlight the innovative spirit at the University of Galway but also underscore the commitment of the European Union to advancing medical research. The funding is expected to significantly contribute to the development of more effective and inclusive medical treatments, positively impacting diverse populations across Europe.